Skip to content

Clinical trials

Angioedemas, Hereditary trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angioedemas, Hereditary Country / region: United Kingdom Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20092
20121
20131
20144
20151
20164
20173
20184
20192
20201
20214
20228
20233
20243
20257
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed33
Active, not recruiting8
Enrolling by invitation5
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioCryst Pharmaceuticals14
KalVista Pharmaceuticals, Ltd.7
Pharvaris Netherlands B.V.7
Shire5
Astria Therapeutics, Inc.4
CSL Behring3
Intellia Therapeutics3
Takeda3
ADARx Pharmaceuticals, Inc.2
Ionis Pharmaceuticals, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angioedemas, Hereditary51
Angioedema6
Hereditary Angioedema Types I and II5
Hereditary Angioedema Type III2
Abdominal Pain1
Genetic Diseases, Inborn1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.